US · HELP
Cybin Inc. Common Stock
- Sector
- Healthcare · Biotechnology
- Headquarters
- Toronto, ON M5X 1C9
- Website
- helus.com
Price · as of 2026-09-03
$11.77
Market cap 652.69M
Price history
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | $934.95 | +7,844% |
| P/E | -0.98 | |
| P/B | 0.62 | |
| P/S | -3.23 | |
| EV/EBITDA | 0.09 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | $49.99 | ||||
| 2020 | $19.89 | ||||
| 2021 | $58.14 | ||||
| 2022 | $25.46 | ||||
| 2023 | $9.20 | ||||
| 2024 | $11.02 | ||||
| 2025 | $8.90 | ||||
| 2026 | $4.15 | $934.95 |
Line items
Line items
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Growth | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| HELP | Cybin Inc. Common Stock | $11.61 | 652.69M | $934.95 | +7,953% | -0.98 | 0.62 | -3.23 | 0.09 | -13285.41% |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($934.95 ÷ $11.77) − 1 = +7,843.5% (IC, example).